Core Insights - Beijing has officially launched its first Zhongguancun (Changping) Brain Science and Brain-Computer Interface Industrial Cluster and Park, along with a development action plan and supporting policies for the brain science and brain-computer interface industry [1][2] Group 1: Policy and Development Plans - The action plan aims to establish a scale for the industrial cluster by 2027, promoting the application of new technologies, products, and models across various scenarios [1] - By 2030, the industrial cluster is expected to be fully established, with innovation capabilities and comprehensive strength reaching international first-class levels, targeting the formation of a new hundred-billion-level future industry cluster [1][2] Group 2: Support Measures - Changping District has proposed policy measures focusing on supporting technological innovation breakthroughs, enterprise cluster development, and industrial ecosystem construction [2] - A comprehensive service system combining "park + investment + incubation + clinical" will be established to create a conducive environment for enterprises, facilitating the rapid landing and development of key enterprises, platforms, and talents [2] Group 3: Strategic Importance - Brain-computer interface technology is highlighted as a cutting-edge technology at the intersection of biological and information sciences, representing future industries and new productive forces, becoming a focal point in global technological competition [2] - Changping is positioned as a key area for Beijing's international innovation center and pharmaceutical health industry development, with unique advantages in developing the brain science and brain-computer interface industry, including the presence of national-level research institutions and leading scientific teams [2]

Core Insights - Beijing is establishing a new industrial pattern for brain science and brain-computer interface (BCI) industries, with the unveiling of the Zhongguancun (Changping) BCI industrial cluster and park [1][2] - The Changping district is focusing on innovation-driven development, financial empowerment, and ecological construction to enhance the BCI industry [2][4] - By 2030, the goal is to create a new hundred-billion-level future industry cluster in the BCI sector [3][4] Group 1: Industrial Development - The Zhongguancun (Changping) BCI industrial cluster aims to leverage the core role of the Zhongguancun Life Science Park to accelerate enterprise incubation and result transformation [1][3] - The Changping district is initiating the BCI Innovation Partnership Plan to strengthen basic research, technological breakthroughs, and integrated innovation [2][4] - The district has already attracted 22 key BCI enterprises, indicating a growing industrial cluster effect [5] Group 2: Policy and Support Measures - Changping has introduced a comprehensive action plan and supporting policies for BCI industry development, focusing on technology innovation, enterprise cluster development, and industrial ecosystem construction [3][4] - The district plans to create a "park + investment + incubation + clinical" service system to support various innovation entities [4] - A strategic partnership has been formed between Chang Development Group and Daoyuan Capital to inject financial resources into the BCI industry [2][4] Group 3: Research and Clinical Applications - Changping is home to national-level research institutions and top medical facilities, providing a robust ecosystem for research and clinical applications in BCI technology [4][5] - The district has seen significant technological achievements, with two major BCI breakthroughs recognized at the 2025 Zhongguancun Forum [5] - The presence of over one million square meters of high-standard industrial space supports the full chain of research, pilot testing, and industrialization [4]

Core Viewpoint - The Sichuan Provincial Government has issued an implementation plan for the development and expansion of emerging industries, focusing on breakthroughs in original technology and the cultivation of future industries from 2025 to 2027 [1] Group 1: Technological Focus - The plan emphasizes innovation in brain science and brain-machine interface technology, aiming to strengthen the collection and processing of neural signals, as well as the assessment and regulation of brain states [1] - It aims to create a source of original technology by promoting the development of high-end equipment products such as brain-machine interface products, surgical robots, and rehabilitation robots with independent intellectual property rights [1] Group 2: Industry Development - Leading enterprises are encouraged to strategically position themselves for advancements in brain-like intelligence and accelerate the research and development of software products [1] - The plan includes the promotion of intelligent diagnostic and therapeutic technologies for neuropsychiatric disorders and brain impact-assisted rehabilitation technologies [1] Group 3: Application and Promotion - The government will select and publish a list of typical application scenarios and recommended directories to encourage the creation of differentiated and characteristic benchmark demonstration scenarios [1] - High-level matchmaking activities will be organized to accelerate the promotion of new technologies and products based on these scenarios [1]

Core Insights - The Beijing Brain Science and Brain-like Research Institute is making significant advancements in brain-machine interface (BMI) technology, which is crucial for improving the quality of life for patients with severe neurological conditions [2][4][6] - The institute has developed the "North Brain No. 1" system, which is the first high-throughput, wireless, fully implanted BMI system with over 100 channels, and it has entered clinical verification stages [2][4] - The research focuses on four main areas: brain cognitive principles, major brain diseases, new technologies in neuroscience, and neural decoding and computation [6][7] Group 1: Brain-Machine Interface Developments - The "North Brain No. 1" system allows for real-time decoding of brain signals, enabling patients to control devices through thought, with a notable accuracy of 63% in decoding common phrases for patients with speech impairments [3][4] - The institute has successfully completed surgeries for five patients with spinal cord injuries and ALS, demonstrating significant improvements in motor functions and the ability to perform tasks previously impossible [3][4] - The upcoming "North Brain No. 2" system aims to implant electrodes deeper into brain tissue for more precise signal capture, enhancing the control capabilities for patients [4] Group 2: Gene Therapy Innovations - The institute is also pioneering gene therapy techniques to treat conditions such as severe epilepsy and vision loss, with a new drug that can be injected directly into the epilepsy focus area to control seizures while preserving normal neural function [7] - A novel light-sensitive protein has been developed for visual restoration in patients with retinal diseases, showing significant improvements in vision for treated patients [6][7] - The institute has established a biotechnology company to facilitate the transition from basic research to clinical applications, aiming to shorten the time for technology commercialization [7]